Answers are grounded in this paper and cite their sources.
This Viewpoint describes the public health implications of high inhaler costs for patients with asthma and chronic obstructive pulmonary disease.
No takes yet. Share an insight, caveat, or question.
Mein et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: